Med-Immune Science
Manufacturer of biopharmaceutical drugs intended to advance the development of macromolecular therapies for cancer and immune-related disorders. The company offers antibody discovery platforms and mac...
Valuation
—
Share Price
N/A
Total Raised
$21.5M
Last Round
N/A